Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/23/14 → 6/23/17 |
Funding
- inVentiv Health Clinical (6002-014 // 6002-014)
- Kyowa Hakko Kirin Pharma, Inc. (6002-014 // 6002-014)
Prot # 6002-04: A Phase 3, 12-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study to Evaluate the Efficacy of Oral Istradefylline 20 and 40 mg/day as Treatment for Subjects with Moderate to Severe Parkinson's Disease
- Zadikoff, Cindy (PD/PI)
Project: Research project